Despite a Supreme Court ruling against the president's broad reciprocal tariffs, the administration is expected to re-impose them using more targeted, sector-specific legal authorities. This means economic relief from lower tariffs will be short-lived, as the underlying protectionist policy stance remains.

The current pharma tariffs are based on a "national security provision" (Section 232), which has a more secure legal footing than prior, successfully challenged tariff orders. Drawing parallels to long-standing steel and China tariffs, companies should strategize for this as a permanent feature of the trade landscape, not a temporary policy.

Even if the Supreme Court rules against the administration, it may not change U.S. tariff levels. The executive branch has alternative legal authorities, like Section 301, that it can use to maintain the same tariffs, making a court defeat less of a market-moving event than it appears.

While the base case is that the President would replace tariffs struck down by the Supreme Court, there's a growing possibility he won't. The administration could use the ruling as a politically convenient way to reduce tariffs and address voter concerns about affordability without appearing to back down on trade policy.

Because U.S. tariff levels are likely to remain stable regardless of legal challenges, the more critical factor for the long-term outlook is how companies adapt. Investors should focus on corporate responses in capital spending and supply chain adjustments rather than the tariff levels themselves.

The legal underpinnings of US tariffs are changing, moving from temporary IEPA authorities to more durable Section 301 and 232 investigations. Despite this complex legal transition, economists expect the aggregate effective tariff rate to remain roughly the same, stabilizing around 10% from a macro perspective.

The Trump-era tariffs are not a temporary political maneuver but a lasting shift in U.S. economic policy. This reflects a broader, bipartisan move towards "spherification," prioritizing supply chain resilience and national security. A future Democratic administration is expected to maintain them.

The temporary 15% tariffs under Section 122 expire near the midterm elections. Given the political unpopularity of high tariffs, it is unlikely the administration will raise them further in the medium term, effectively capping rates at this level to appeal to voters concerned about affordability.

Following the ruling, Trump immediately invoked Section 122 of the Trade Act to impose a 10% tariff. This authority is limited—up to 15% for only 150 days. This creates a ticking clock for his administration to build more complex legal cases under other statutes, like Section 301, to make the tariffs permanent.